Endo to pay $2 bn to settle US charges on opioid crisis

Endo Health Solutions has agreed to pay $2 billion to settle civil and criminal charges related to mislabeling the pain reliever drug Opana, which contributed to the opioid epidemic. The agreement includes a criminal plea where the company admitted to mislabeling Opana, marketing it for non-medically accepted purposes, and misleading healthcare providers regarding its abuse deterrence. Endo will pay a criminal fine of $1.1 billion and $450 million in criminal forfeiture, as well as $475.6 million under a civil settlement. The company also committed to operating with integrity and ethics, and will pay the government up to $464.9 million over 10 years.

Source link

error: Content is protected !!